ERBB2 and neoplasm: The secreted HER2-CD3-Fc bsAb binds to both HER2 and CD3 and induces potent T cell cytotoxicity and cytokine secretion against multiple HER2-positive tumor cells, including MDA-MB-231 cells with low HER2 expression.